Aardvark Therapeutics AARD
NASDAQ AARD
$4.02 -0.39 (-8.77%)
As of: Oct 22, 2026 · 9:53 AM EDT

Aardvark Therapeutics (AARD) Ending Cash Balance (2024 - 2026)

Updated

Analysis

Aardvark Therapeutics (AARD) Ending Cash Balance (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,157.52 Bn 1,126.11 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 631.39 Bn 549.92 Bn 17.26 Bn 20.42 Bn
3 AbbVie 498.93 Bn 472.04 Bn 12.70 Bn 6.57 Bn
4 Merck 376.05 Bn 330.42 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 301.98 Bn 265.97 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn 4.88 Bn
7 Amgen 240.27 Bn 195.67 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.08 Bn 167.27 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.85 Bn 118.50 Bn 10.94 Bn 1.03 Bn
10 Aardvark Therapeutics 87.87 Mn 13.97 Mn - 73.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 73.85 Mn
Mar 31, 2026 62.44 Mn
Dec 31, 2025 47.05 Mn
Sep 30, 2025 39.29 Mn
Jun 30, 2025 26.00 Mn
Mar 31, 2025 26.50 Mn
Dec 31, 2024 61.64 Mn
Sep 30, 2024 82.28 Mn
Jun 30, 2024 86.17 Mn
Mar 31, 2024 7.54 Mn
API Access

Aardvark Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=AARD&period=max&api_key=YOUR_API_KEY